The 5000% case: a glimpse into the financial issue of lung cancer treatment

Eur Respir J. 2016 May;47(5):1331-3. doi: 10.1183/13993003.00548-2016.

¹ Medical Oncology Dept, Institute Gustave Roussy, Villejuif, France.
² Service de biostatistique et d'épidémiologie, Institute Gustave Roussy, Villejuif, France CESP Centre for Research in Epidemiology and Population Health, INSERM U1018, Université Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif, France.
³ Medical Oncology Dept, Institute Gustave Roussy, Villejuif, France Université Paris-Sud and Institute Gustave Roussy Cancer Campus, Villejuif, France Benjamin.BESSE@gustaveroussy.fr.

No abstract available

Publication types